Direct oral anticoagulants
220 results
201 - 220
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
Lumbar puncture 
For atrial fibrillation with stable coronary artery disease, edoxaban alone prevents more bad outcomes than edoxaban plus an antiplatelet agent- A new bleeding risk score predicts major bleeding better than other scores in elderly patients who take DOACs
- Optimal treatment of acute venous thromboembolism
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Angioplasty or stenting for deep venous thrombosis
- Acute coronary syndrome
- Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults: Cochrane systematic review
- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Fewer major bleeds with edoxaban than with warfarin, but treatment benefit unclear (ENGAGE-AF)
- Cerebral infarction (ischaemic stroke)
- Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage
- COVID-19 and other coronavirus infections
- Prevention of venous thromboembolism
- Antiplatelet therapy for prevention of death, myocardial infarction, and stroke
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery